Metabolic flux analysis and pharmaceutical production

被引:82
作者
Boghigian, Brett A. [2 ]
Seth, Gargi [1 ]
Kiss, Robert [1 ]
Pfeifer, Blaine A. [2 ]
机构
[1] Genentech Inc, Proc Res & Dev, San Francisco, CA 94080 USA
[2] Tufts Univ, Dept Chem & Biol Engn, Ctr Sci & Technol, Medford, MA 02155 USA
关键词
MFA; FBA; Escherichia coli; CHO; Hybridoma; C-13; labeling; COMPLETE GENOME SEQUENCE; HUMAN RED-CELL; BIOCHEMICAL SYSTEMS-ANALYSIS; ESCHERICHIA-COLI STRAINS; NATURAL-PRODUCTS; SCALE RECONSTRUCTION; LYCOPENE PRODUCTION; PATHWAY ANALYSIS; BALANCE MODELS; WILD-TYPE;
D O I
10.1016/j.ymben.2009.10.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rational engineering of biological systems is an inherently complex process due to their evolved nature. Metabolic engineering emerged and developed over the past 20 years as a field in which methodologies for the rational engineering of biological systems is now being applied to specific industrial, medical, or scientific problems. Of considerable interest is the determination of metabolic fluxes within the cell itself, called metabolic flux analysis. This special issue and this review have a particular interest in the application of metabolic flux analysis for improving the pharmaceutical production process (for both small and large molecules). Though metabolic flux analysis has been somewhat limited in application towards pharmaceutical production, the overall goal is to: (1) have a better understanding of the organism and/or process in question, and (2) provide a rational basis to further engineer (on both metabolic and process scales) improved pharmaceutical production in these organisms. The focus of this review article is to present how experimental and computational methods of metabolic flux analysis have matured, mirroring the maturation of the metabolic engineering field itself, while highlighting some of the successful applications towards both small- and large-molecule pharmaceuticals. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 95
页数:15
相关论文
共 205 条
[61]   Metabolic flux profiling of Escherichia coli mutants in central carbon metabolism using GC-MS [J].
Fischer, E ;
Sauer, U .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (05) :880-891
[62]   High-throughput metabolic flux analysis based on gas chromatography-mass spectrometry derived 13C constraints [J].
Fischer, E ;
Zamboni, N ;
Sauer, U .
ANALYTICAL BIOCHEMISTRY, 2004, 325 (02) :308-316
[63]  
Follstad BD, 1999, BIOTECHNOL BIOENG, V63, P675, DOI 10.1002/(SICI)1097-0290(19990620)63:6<675::AID-BIT5>3.0.CO
[64]  
2-R
[65]   Using isotopomer path tracing to quantify metabolic fluxes in pathway models containing reversible reactions [J].
Forbes, NS ;
Clark, DS ;
Blanch, HW .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 74 (03) :196-211
[66]   Life with 6000 genes [J].
Goffeau, A ;
Barrell, BG ;
Bussey, H ;
Davis, RW ;
Dujon, B ;
Feldmann, H ;
Galibert, F ;
Hoheisel, JD ;
Jacq, C ;
Johnston, M ;
Louis, EJ ;
Mewes, HW ;
Murakami, Y ;
Philippsen, P ;
Tettelin, H ;
Oliver, SG .
SCIENCE, 1996, 274 (5287) :546-&
[67]   Error Propagation from Prime Variables into Specific Rates and Metabolic Fluxes for Mammalian Cells in Perfusion Culture [J].
Goudar, Chetan T. ;
Biener, Richard ;
Konstantinov, Konstantin B. ;
Piret, James M. .
BIOTECHNOLOGY PROGRESS, 2009, 25 (04) :986-998
[68]   In silico genome-scale reconstruction and validation of the Staphylococcus aureus metabolic network [J].
Heinemann, M ;
Kümmel, A ;
Ruinatscha, R ;
Panke, S .
BIOTECHNOLOGY AND BIOENGINEERING, 2005, 92 (07) :850-864
[69]   LINEAR STEADY-STATE TREATMENT OF ENZYMATIC CHAINS - GENERAL PROPERTIES, CONTROL AND EFFECTOR STRENGTH [J].
HEINRICH, R ;
RAPOPORT, TA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1974, 42 (01) :89-95
[70]   Thermodynamics-based metabolic flux analysis [J].
Henry, Christopher S. ;
Broadbelt, Linda J. ;
Hatzimanikatis, Vassily .
BIOPHYSICAL JOURNAL, 2007, 92 (05) :1792-1805